A new U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Olivier George from TSRI. Dr. Palmer is a co-investigator on this project, which will use HS rats to perform a GWAS for extended access to oxycodone. The grant (U01DA044451-01A1) titled “Use of Next-Gen Sequencing to Identify Genetic Variants that Influence Compulsive Oxycodone Intake in Outbred Rats” will start on April 1, 2018 and will end January 31, 2023.
Drs. Olivier George and Abraham Palmer awarded NIDA U01 grant
Posted under: Funding & Grants